[190 Pages Report] The global radiopharmaceuticals market stands at US$ 6.2 Bn as of now and is expected to reach US$ 9.5 Bn by the year 2032 at a CAGR of 4.3% between 2022 and 2032. Radiopharmaceuticals imply medications containing radioisotopes that could be used as both – therapeutic agents and diagnosis medications. Radiopharmaceuticals manage critical as well as …
Category Archives: Healthcare Trends
Patient-Controlled Analgesia Pumps Market is expected to reach US$ 699.9 Mn by 2032 | FMI
The global Patient-Controlled Analgesia Pumps Market is expected to be worth US$ 421.9 million in 2022 and to grow at a 5.2% CAGR to reach US$ 699.9 million by 2032. According to a recent analysis by Future Market Insights, PCA pumps would have a global market share of roughly 75.5% in 2021. With the latest …
Outpatient Clinics Market is projected to reach ~US$ 58.9 Bn by 2032 | FMI
The global Outpatient Clinics Market is estimated to be worth US$ 39.0 billion by the end of 2022, and to grow at a CAGR of 4.2% from 2022 to 2032. By the end of 2032, the market is expected to be worth US$ 58.9 billion. Primary care clinics are the market leaders, with a market share …
Continue reading “Outpatient Clinics Market is projected to reach ~US$ 58.9 Bn by 2032 | FMI”
Drug of Abuse Testing Market Share is Expected To See a growth of 5% by 2031-end | Future Market Insights
According to a recent market report by Future Market Insights, the global Drug Of Abuse Testing Market share is expected to exceed US$ 1.5 billion in 2021, expanding at a CAGR of more than 5% over the forecast period. Growth can be attributed to the increasing opioid dependence in the geriatric population as a result …
Radiopharmaceuticals Market is expected to reach US$ 9.5 Billion by 2032 | FMI
The Radiopharmaceuticals Market is expected to be valued US$ 6.2 billion in 2022, according to Future Market Insights (FMI). During the projected period of 2022-2032, radiopharmaceutical consumption is expected to grow at a 4.3% CAGR to reach US$ 9.5 billion. North America will account for more than 47% of the global market due to increased …
Continue reading “Radiopharmaceuticals Market is expected to reach US$ 9.5 Billion by 2032 | FMI”
Infusion Pumps Market is expected to reach US$ 6.6 Bn by 2030 | Says FMI Analyst
According to a recent market analysis conducted by Future Market Insights (FMI), the global Infusion Pumps Market was valued at US$ 4.4 billion in 2022 and is anticipated to reach US$ 6.6 billion by 2030. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an …
Continue reading “Infusion Pumps Market is expected to reach US$ 6.6 Bn by 2030 | Says FMI Analyst”
3D-Printed Maxillofacial Implants Market is expected to reach US$ 1,100.4 Million in 2032 at a CAGR of 8%
The global market for 3D-Printed maxillofacial implants is expected to grow at an 8% CAGR, reaching a market value of US$ 1,100.4 million in 2032, up from US$ 474.2 million in 2022. The global 3-D printed maxillofacial implants market grew at a 6.7% CAGR between 2016 and 21. Increased demand for 3-D printed maxillofacial implants due to …
Light Curable Flowable Composite Market | 3M-ESPE, Dentsply, Ivoclar, Kerr-Sybron | By 2027
Future Market Insights (FMI) presents its new, comprehensive study on the global Light Curable Flowable Composite market spanning from 2017 to 2027. Researches at FMI have no left no stone unturned in bestowing readers a comprehensive view of the market, by studying the drivers, trends, challenges, and restraints. Backed by historical data and projected data, the report …
In-Ear-Monitors (IEMs) Market | Shure Incorporated, Future Sonics Inc., Peavey Electronics, ULTIMATE EARS. | By 2032
The In-Ear-Monitors (IEMs) Market is anticipated to reach a valuation of US$ 344.7 million in 2022 and grow at a CAGR of 9.0% to reach US$ 749.7 million by 2032. In 2021, the universal IEM in the product segment will dominate the global market, with a share of roughly 56.5%, according to a recent analysis …
Vulvodynia Treatment Market | Eli Lilly and Company, AstraZeneca Plc., GlaxoSmithKline Plc., Pfizer Inc. | 2028
According to the report, the global Vulvodynia Treatment Market is expected to register a CAGR of 6.3% over the forecast period of 2022 and 2028. The market was worth US$ 4,261.2 Mn in 2021 and is expected to rise to a valuation of US$ 8 Bn by the end of 2028. Future Market Insights (FMI) …